Matthew Mega Email & Phone Number

Austin, Texas, Us

Durham, North Carolina, Us

Successfully led the organizational objective of securing CMS reimbursement via Palmetto MolDx Local Coverage Determination for InVisionFirst-Lung ctDNA assay for advanced non-small cell lung cancer patients. Directed dossier development, managed engagement with key contacts, developed content and messaging for payer and physician influencers that resulted in CMS Final LCD in February 2019.

Redwood City, Ca, Us

Resource and strategy lead for all Oncology Franchise products (ODX Breast N-/N+, ODX Breast DCIS, ODX Colon, ODX Seq) to ensure continued and expanded access to reimbursement. Led the development and implementation of the reimbursement strategy for GHI's NGS-based ODX Seq Liquid-Biopsy panel for metastatic cancer. Additionally tasked with defending access and reimbursement of the ground-breaking market leader, ODX Breast.

Redwood City, Ca, Us

Strategic lead responsible for short/long term business planning for existing (ODX) and emerging (NGS) products to support the success of the Managed Care Team in their pursuit of coverage, contracting, and reimbursement for GHI's expanding portfolio of advanced diagnostic laboratory-developed tests (ADLTs).

Redwood City, Ca, Us

Responsible for the development and implementation of GHI Strategic Markets Division. Created Managed Markets business strategy identifying opportunities outside the traditional payer/provider revenue stream in order to defend and expand value based pricing, insulate from competition, and increase utilization via national level initiatives. Simultaneously developed Managed Care Training platform consisting of business model principles, manager and account manager training program, and integration of STAR model attributes to business planning, employee development, and performance evaluation. Also maintained account responsibilities with United Healthcare resulting in the successful renegotiation of contracting terms while maintaining reimbursement rates and expanding coverage for additional patient access and increased corporate revenue.

Redwood City, Ca, Us

Developed significant relationships with national and regional payer groups by demonstrating value and identifying unforeseen business opportunities elevating status with many accounts to that of a trusted business adviser. Negotiated pricing, secured in-network status, and established positive medical policy supporting increased utilization of GHI services.

Redwood City, Ca, Us

Worked with academic and community based medical and surgical oncologists on the appropriate use and value of the Oncotype DX Breast Cancer Assay in assessing risk and determining treatment for early stage breast cancer patients.

Cambridge, Cambridgeshire, Gb

Facilitated expanded utilization of AZ oncology pharmaceuticals for the treatment of early stage and metastatic breast cancer, adjuvant prostate cancer, and late stage non-small cell lung cancer.

Executive Education, Strategic Marketing

Ms, Exercise Physiology

Ba, Communications